Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal inhalation of tobramycin with the Pari Sinus nebulizer in cystic fibrosis patients
2008-000164-17Phase 2Terminated
- Sponsor
- Friedrich Schiller University Jena
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection, sponsored by Friedrich Schiller University Jena. Primary endpoints: Reduction of Pseudomonas aeruginosa in nasal lavage fluid and Drug safety of nasal tobramycin (pilot study). Started May 2008; status: terminated.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2008-000164-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000164-17.